Table 2: Comparison of echocardiographic variables before and after TAVI.
CoreValve Group (n ═ 56) | Edwards SAPI (n ═ 41) | |||||||||
Pre-TAVI | 1st month | 6th month | p1 | p2 | Pre-TAVI | 1st month | 6th month | p1 | p2 | |
Maximal gradient (mmHg) | 76.39 ± 13.29 | 18.60 ± 5.56 | 15.67 ± 5.33 | < 0.001 | < 0.001 | 82.48 ± 14.37 | 20.48 ± 3.09 | 20.21 ± 2.62 | < 0.001 | < 0.001 |
Mean gradient (mmHg) | 47.81 ± 8.30 | 9.94 ± 2.91 | 7.96 ± 2.77 | < 0.001 | < 0.001 | 44.95 ± 7.14 | 9.29 ± 1.83 | 9.31 ± 1.66 | < 0.001 | < 0.001 |
LV ejection fraction (%) | 51.46 ± 9.43 | 55.05 ± 6.98 | 56.76 ± 5.85 | < 0.001 | < 0.001 | 49.24 ± 8.14 | 52.96 ± 7.49 | 55.02 ± 7.36 | < 0.001 | < 0.001 |
IVS (mm) | 13.9 ± 1.6 | 12.4 ± 1.4 | 11.5 ± 0.9 | < 0.001 | < 0.001 | 14.5 ± 1.4 | 12.9 ± 0.7 | 10.8 ± 0.9 | < 0.001 | < 0.001 |
PWT (mm) | 13.0 ± 1.4 | 11.8 ± 1.1 | 11.3 ± 0.8 | < 0.001 | < 0.001 | 12.7 ± 0.7 | 11.6 ± 0.7 | 11.6 ± 0.7 | < 0.001 | < 0.001 |
LVEDD (cm) | 4.85 ± 0.56 | 4.81 ± 0.52 | 4.62 ± 0.45 | 0.001 | < 0.001 | 5.08 ± 0.66 | 5.03 ± 0.61 | 4.88 ± 0.58 | 0.008 | < 0.001 |
RWT (g/m2) | 0.55 ± 0.08 | 0.50 ± 0.07 | 0.49 ± 0.06 | < 0.001 | < 0.001 | 0.52 ± 0.09 | 0.47 ± 0.07 | 0.45 ± 0.07 | < 0.001 | < 0.001 |
LV mass (g) | 265.9 ± 59.1 | 226.7 ± 51.5 | 195.3 ± 39.0 | < 0.001 | < 0.001 | 289.1 ± 48.1 | 245.4 ± 46.7 | 210.4 ± 39.7 | < 0.001 | < 0.001 |
LVMI (g/m2) | 144.5 ± 31.6 | 123.1 ± 27.3 | 106.0 ± 21.1 | < 0.001 | < 0.001 | 160.9 ± 35.7 | 136.6 ± 32.9 | 117.0 ± 27.1 | < 0.001 | < 0.001 |
AVA (cm2) | 0.77 ± 0.12 | 1.64 ± 0.15 | 1.64 ± 0.15 | < 0.001 | < 0.001 | 0.80 ± 0.11 | 1.66 ± 0.14 | 1.65 ± 0.13 | < 0.001 | < 0.001 |
TAVI: Transcatheter Aortic Valve İmplantation; LV: Left ventricular; IVS: Interventricular Wall Thickness; PWT: Posterior Wall Thickness; LVEDD: Left Ventricular End-Diastolic Dimension; RWT: Relative Wall Thickness; LVMI: Left Ventricular Mass İndex; AVA: Aortic Valve Area p1: Comparison of preprocedural values with those at 1 month ; p2: Comparison of preprocedural values with those at 6 months.